Non-thrombolysed patients (n=2019) | Thrombolysed patients (n=599) | |||
---|---|---|---|---|
n or median | % or quartiles | n or median | % or quartiles | |
Age (years) | 73 | 61, 82 | 69 | 58, 78 |
Sex (male) | 1131 | 56.0% | 349 | 58.3% |
Onset-to-door time (min) | 337 | 125, 774 | 93 | 58, 135.5 |
Onset to admission ≤180 min | 659 | 32.6% | 523 | 87.3% |
Admission NIHSS | 4.5 | 2, 10 | 13 | 8, 19 |
Treated in first observation period (2003–2006) | 959 | 47.5% | 173 | 28.9% |
Hypertension | 1317 | 65.2% | 346 | 57.8% |
Hyperlipidaemia | 1296 | 64.2% | 362 | 60.4% |
Atrial fibrillation | 488 | 24.2% | 156 | 26.0% |
Active smoking | 434 | 21.5% | 136 | 22.7% |
Diabetes mellitus | 332 | 16.4% | 97 | 16.2% |
Symptomatic coronary artery disease* | 295 | 14.6% | 85 | 14.2% |
Symptomatic peripheral artery disease | 106 | 5.3% | 23 | 3.8% |
Low ejection fraction (<35%) | 84 | 4.2% | 34 | 5.7% |
Cancer not in remission | 77 | 3.8% | 14 | 2.3% |
Heart valves | 64 | 3.2% | 10 | 1.7% |
*Documented by myocardial infarct diagnosis, coronarography or stress test.
NIHSS, National Institute of Health Stroke Scale score.